• Company
    • About Siamab Therapeutics
    • Team
    • Advisors
    • Investors
    • Contact
  • Research & Development
    • Platform
    • Pipeline
    • Publications
  • News
    • Press Releases
    • Featured News
  • Careers
Siamab Therapeutics
  • Home
  • Contact
MENU
  • Company
    • About Siamab Therapeutics
    • Team
    • Advisors
    • Investors
    • Contact
  • Research & Development
    • Platform
    • Pipeline
    • Publications
  • News
    • Press Releases
    • Featured News
  • Careers

Press Releases

Featured News

 

Featured News


July 14, 2014
Medcity News: Siamab Therapeutics -- New funding, new name, new direction in cancer immunotherapy

January 24, 2014
Fierce Biotech: Pulse of J.P. Morgan 2014: Interviews with 17 biopharma execs

July 31, 2013
Medcity News: Pharma firm bets sialic acid could help explain link between diet and inflammatory diseases

January 3, 2013
Xconomy: Sialix Moves into SD’s Janssen Labs to Focus on Inflammatory Target

October 10, 2012
Medcity News: Sialix Receives $2M Extension on Series B Round

October 4, 2012
Bioworld: Momenta Seizes on Sialix mAb Therapeutic Program

April 20, 2011
Bioworld: How Foreign Is Too Foreign? Sort-of Foreigner Could Be Cancer Diagnostic, Target

 

© 2015 Siamab Therapeutics